Track topics on Twitter Track topics that are important to you
MethylGene is engaged in the discovery and development of drugs for diseases for which there are currently limited or no treatments. Research on the Company's first target, the DNA Methyltransferase enzyme, has yielded a unique anti-cancer drug presently in Phase I clinical trials. Several other targets are being investigated, including HDAC (histone deacetylase) and ER-1 (early response gene) for cancer as well as ß-Lactamase for infectious diseases. With in vivo evidence of efficacy, discoveries have notably given rise to a novel class of small molecule ß-Lactamase inhibitor which may aid in the fight against antibiotic resistance; while on the cancer front, small molecule HDAC inhibitors are showing promise. With its solid biology and chemistry platforms, MethylGene is entering the 21st century with a dedication to improving people's health and quality of life.
7220 Frederick-Banting, Suite 200
Phone: 514 337 3333
Fax: 514 337 0550
LIVINGSTON, NJ --(Marketwired - September 14, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a medical company that develops and commercializes a growing portfolio of propri...
Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...
MethylGene is engaged in the discovery and development of drugs for diseases for which there are currently limited or no treatments. Research on the Company's first target, the DNA Methyltransferase e...
MethylGene is a publicly-traded biopharmaceutical company listed on the Toronto Stock Exchange under the symbol MYG. We focus in the areas of cancer, infectious disease and other diseases such as diab...
PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...
Founded in 2008 by the Axis Biotec Brasilâ¢ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....
COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...
We have published hundreds of MethylGene Incorporated news stories on BioPortfolio along with dozens of MethylGene Incorporated Clinical Trials and PubMed Articles about MethylGene Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MethylGene Incorporated Companies in our database. You can also find out about relevant MethylGene Incorporated Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...